Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2

BACKGROUND: There is a need for feasible, scalable assessments to detect cognitive impairment and decline. The Cogstate Brief Battery (CBB) is validated for Alzheimer’s disease (AD) and in unsupervised and bring your own device contexts. The CBB has shown usability for self-completion in the home bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Edgar, Chris J., Siemers, Eric, Maruff, Paul, Petersen, Ronald C., Aisen, Paul S., Weiner, Michael W., Albala, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543269/
https://www.ncbi.nlm.nih.gov/pubmed/34366337
http://dx.doi.org/10.3233/JAD-210201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543269/
https://www.ncbi.nlm.nih.gov/pubmed/34366337
http://dx.doi.org/10.3233/JAD-210201

Ejemplares similares